# Progress Note 05 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Theodore Roosevelt (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI012-SYN-TD
- Date: 1882-09-14
- Fictional facility: St. Posthumous Health Center
- Fictional author: Amos Kettering, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Six-month asthma review after a summer exacerbation. **S**

## History of present illness

Mr. Roosevelt returns for his six-month review. Six weeks ago he had a moderate exacerbation with a cold, treated at a same-day visit with five days of prednisone 40 mg. The nurse telephone check three days later found his peak flow back above 500 L/min. He was not seen in clinic within the week afterwards, as his plan advised, because the appointment was never booked. He recovered fully within ten days and returned to training after two weeks. Since then he has had no night waking, no daytime symptoms apart from before training, and peak flows of 580 to 610 L/min. He takes every maintenance dose. **S**

| Element | Detail |
|---|---|
| Interval history | Moderate exacerbation with a cold six weeks ago; five days of prednisone; full recovery |
| Post-exacerbation follow-up | Telephone check at three days; no clinic review within one week |
| Reliever use | One inhalation before training; none otherwise |
| Home peak flow | 580 to 610 L/min |
| Adherence | Full |
| Exacerbations in the past 12 months | Two oral corticosteroid courses: one last winter before controller therapy and one six weeks ago |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Respiratory | Negative | No cough, wheeze, or night symptoms |
| Constitutional | Negative | No fever; energy back to normal |
| Endocrine | Negative | No thirst, sleep disturbance, or mood change after the prednisone course |

3 systems reviewed. **S**

## Current medications

- Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenance **S**
- Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in total **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/72 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 73.2 kg; BMI 23.9 kg/m². All vital signs are synthetic.

Peak expiratory flow: 590 L/min; Asthma Control Test: 21. All results are synthetic.

## Change since baseline

- Asthma Control Test: 13 at baseline, 21 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Mouth | No thrush |
| Lungs | Clear |
| Inhaler technique | Correct with his own inhaler and spacer |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Moderate persistent asthma, well controlled with a recent exacerbation** (J45.40). Asthma Control Test 21 and peak flow 590 L/min, so current control is good. The exacerbation six weeks ago is a risk factor for another, so stepping down now is not advised. Adherence and technique are good and the trigger was a viral cold, so stepping up is not needed either. He does not meet criteria for severe asthma or for a biologic. **S**
   - Continue budesonide-formoterol two inhalations twice daily and one as needed.
   - Action plan reviewed after the exacerbation; he will call on day two of any yellow-zone cold, and post-exacerbation reviews are now booked before he leaves the sick visit.
   - Reassess step-down at the next review if he has had no further exacerbation.
   - Influenza vaccine at next month's preventive visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Asthma Control Test | Every visit | Completed today | 21, well controlled |
| Examination | Peak flow | Daily or with symptoms for moderate to severe asthma | Completed today | 590 L/min, green zone |
| Examination | Inhaler technique with his own device | Every visit | Completed today | Correct |
| Medication safety | Adherence and reliever use | Every visit | Completed today | Full adherence; reliever before training only |
| Survey | Exacerbation history | Every visit | Completed today | One oral corticosteroid course since starting controller therapy, six weeks ago, with a viral cold; no emergency visits or hospital stays |
| Survey | Clinic review within one week of an exacerbation | Within 1 week of any exacerbation | Deferred | Missed: advised at the sick visit but never booked, a deviation from the protocol; only the day-three nurse telephone check took place. No harm resulted: he recovered fully, and today's control and peak flow are good. Corrective action: post-exacerbation reviews are now booked at the sick visit before the patient leaves |
| Self-management | Written asthma action plan | Every visit and after every exacerbation | Completed today | Reviewed and updated after the exacerbation |
| Self-management | Trigger and exposure review, smoking and vaping status | Every visit | Completed today | Viral colds remain his main trigger; never smoker |
| Survey | Step-up or step-down assessment | Every visit | Completed today | No change: step-down deferred because of the recent exacerbation; step-up not needed with good control, adherence, and technique |
| Examination | Spirometry | At diagnosis, 3 to 6 months after stabilization, then every 1 to 2 years | Up to date | Normal three months ago; next in one to two years |
| Referral | Biologic candidacy assessment | Only if severe and uncontrolled despite optimized Step 4 to 5 therapy | Not indicated | One exacerbation on controller therapy, with good control between; criteria for severe asthma not met |
| Medication safety | Vaccination status | Yearly | Due | Influenza vaccine planned at next month's preventive visit |

## Goal progress

- Asthma Control Test score of 20 or more by the three-month review. Outcome by 1882-06-08: ACT rose from 13 to 22. **S**
- FEV1 of 80 percent predicted or more on spirometry after stabilization. Outcome by 1882-06-08: FEV1 89 percent predicted with a normal FEV1/FVC ratio. **S**
- No exacerbation needing oral corticosteroids over the six months after starting controller therapy. Outcome by 1882-09-14: Not met: one moderate exacerbation with a cold in August needed a five-day prednisone course; the goal continues for the next six months. **S**
- Return to full boxing and rowing training without limiting symptoms. Outcome by 1882-06-08: Training fully by the three-month review, using one reliever inhalation before sessions. **S**

## Guideline basis

- Global Strategy for Asthma Management and Prevention, 2025 update (2025), Global Initiative for Asthma
- 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020), National Heart, Lung, and Blood Institute (J Allergy Clin Immunol 2020;146(6):1217-1270)
- CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026), Aether Forge

## Follow-up

- Preventive visit next month. Asthma review in three months, or within one week of any exacerbation. **S**
- Next scheduled visit 1882-10-19: periodic adult preventive visit. **S**
